Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by S100A1 is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. Additionally we are shipping s100 Kits (28) and s100 Proteins (25) and many more products for this protein.
Showing 10 out of 385 products:
Bullfrog (Rana catesbeiana) Polyclonal s100 Primary Antibody for IEM, ICC - ABIN789006
Correale, Procopio, Celio, Caraglia, Genua, Coppola, Pepe, Normanno, Vecchio, Palmieri: Phorbol 12-myristate 13-acetate induces resistance of human melanoma cells to natural-killer- and lymphokine-activated-killer-mediated cytotoxicity. in Cancer immunology, immunotherapy : CII 1992
Show all 22 references for ABIN789006
Human Polyclonal s100 Primary Antibody for EIA, IHC (p) - ABIN954650
Marlatt, Spratt, Shaw: Codon optimization for enhanced Escherichia coli expression of human S100A11 and S100A1 proteins. in Protein expression and purification 2010
Show all 5 references for ABIN954650
Human Monoclonal s100 Primary Antibody for WB - ABIN393494
van Dieck, Lum, Teufel, Fersht: S100 proteins interact with the N-terminal domain of MDM2. in FEBS letters 2010
Show all 5 references for ABIN393494
Cow (Bovine) Polyclonal s100 Primary Antibody for EIA, IHC (p) - ABIN401026
Baudier, Gérard: Ions binding to S100 proteins: structural changes induced by calcium and zinc on S100a and S100b proteins. in Biochemistry 1983
Show all 4 references for ABIN401026
Human Monoclonal s100 Primary Antibody for IHC (p), WB - ABIN1108918
Koenig, Wojcieszyn, Weeks, Modiano: Expression of S100a, vimentin, NSE, and melan A/MART-1 in seven canine melanoma cells lines and twenty-nine retrospective cases of canine melanoma. in Veterinary pathology 2001
Show all 3 references for ABIN1108918
Cow (Bovine) Polyclonal s100 Primary Antibody for IHC (fro), IHC (p) - ABIN121826
Lauriola, Michetti, Sentinelli, Cocchia: Detection of S-100 labelled cells in nasopharyngeal carcinoma. in Journal of clinical pathology 1985
Show all 3 references for ABIN121826
Cow (Bovine) Monoclonal s100 Primary Antibody for FACS, IHC (fro) - ABIN356321
Wosik, Cayrol, Dodelet-Devillers, Berthelet, Bernard, Moumdjian, Bouthillier, Reudelhuber, Prat: Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis. in The Journal of neuroscience : the official journal of the Society for Neuroscience 2007
Show all 2 references for ABIN356321
Cow (Bovine) Polyclonal s100 Primary Antibody for IHC (fro), IF - ABIN356473
Joshi, Lee, Pedersen, Schnitt, Camus, Hughes: The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast. in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1996
Show all 2 references for ABIN356473
identified S100A1, but not calmodulin (show KRIT1 Antibodies) or other S100 proteins, as a potent molecular chaperone (show HSP90AA1 Antibodies) and a new member of the Hsp70 (show HSP70 Antibodies)/Hsp90 (show HSP90 Antibodies) multichaperone complex (S100A1)
Results suggest that S100A1 can act as a linker between the calcium and redox signalling pathways.
beta-mercaptoethanol modification of apo (show C9orf3 Antibodies)-S100A1 makes its structure more similar to that of holo-S100A1, so that it becomes much better adjusted for calcium coordination.
Serum S100B (show S100B Antibodies) protein levels increased after general anaesthesia. The values of S100Bp (median 164.0 ng/L) were significantly higher than the values of S100Bb (median 94.5 ng/L). The median of the difference between S100Bp and S100Bb was 58.0 ng/L. There were statistically significant differences between S100Bb and S100Bp.
Although an elevation in S100B (show S100B Antibodies) was not observed in this (second) ascent during re-exposure to the hypobaric hypoxia of high altitude for either the non-treated (acclimatised) or the dexamethasone treated (acclimatised and dexamethasone) groups, the hypothesis that S100B (show S100B Antibodies) would reduce following acclimatisation could not be statistically confirmed in our study given the wide confidence intervals and small sample size
molecular dynamics simulations of S100A1 in the apo (show C9orf3 Antibodies)/holo (Ca(2 (show CA2 Antibodies)+)-free/bound) states, is reported.
Serum S100B (show S100B Antibodies) is a useful quantitative biomarker in routine follow-up of high-risk melanoma patients.
There was no association found between serum and CSF (show CSF2 Antibodies) S100B (show S100B Antibodies) with radiographic vasospasm or DIND. S100B (show S100B Antibodies) is a potential prognostic marker for aSAH (show ASAH1 Antibodies) outcome
Fetuses of active smoker mothers had lower cord blood S100B (show S100B Antibodies) levels compared to fetuses of non-smoker mothers.
This study inquires into the physiological concentrations of NSE (show ENO2 Antibodies) and S100B (show S100B Antibodies) proteins in CSF (show CSF2 Antibodies), carried out on a sufficiently large group of 601 patients.
Studied circulating S100B (show S100B Antibodies) and adiponectin (show ADIPOQ Antibodies) in children who underwent open heart surgery. S100B (show S100B Antibodies) showed a significant increase from hospital admission up to 24 h after procedure.
Concentrations of serum S100B (show S100B Antibodies) protein in brain-dead organ donors are extremely high and may support the diagnosis of brain death.
long-term exposure to high blood glucose concentrations leads to an increase in total oxidant in patients with diabetic ketoacidosis ( and that the neurotransmitter changes that develop in response to this exposure lead to an increase in S100B (show S100B Antibodies) levels
S100A1-KO exhibited increased right ventricular (RV) weight and elevated RV pressure in the absence of altered left ventricular filling pressures, increase in wall thickness of muscularized pulmonary arteries and a reduction in microvascular perfusion.
S100A1 and S100B (show S100B Antibodies) are dispensable for endochondral ossification during skeletal development.
S100A1 ablationalso reduced plaque associated and increased non-plaque associated PO4-Akt (show AKT1 Antibodies) and PO4-GSK3beta (show GSK3b Antibodies) staining.
Patients with acute myocardial infarction (MI) showed significantly increased S100A1 serum levels. Experimental MI in mice induced comparable S100A1 release. S100A1 signaling in cardiac fibroblasts occurs through endosomal TLR4 (show TLR4 Antibodies)/MyD88 (show MYD88 Antibodies).
hypoxia-induced MiR (show MLXIP Antibodies)-138 is an essential mediator of EC dysfunction via its ability to target the 3'UTR (show UTS2R Antibodies) of S100A1.
Report downregulation of S100A1 expression in critical limb ischemia impairs postischemic angiogenesis via compromised proangiogenic endothelial cell function and nitric oxide synthase (show NOS Antibodies) regulation.
S100A1 and calmodulin (show Calm2 Antibodies) bind to an overlapping domain on the ryanodine receptor (show RYR3 Antibodies) type 1 to tune the Ca2 (show CA2 Antibodies)+ release process, and thereby regulate skeletal muscle function. (Review)
The RyR1 (show RYR1 Antibodies)-L3625D mutation removed both an early activating effect of S100A1 and calmodulin (show Calm2 Antibodies) and delayed the suppression of RyR1 (show RYR1 Antibodies) Ca2 (show CA2 Antibodies)+ release, providing new insights into calmodulin (show Calm2 Antibodies) and S100A1 regulation of skeletal muscle excitation-contraction coupling.
Data suggest that the absence of S100A1 suppresses physiological AP-induced Ca(2 (show CA2 Antibodies)+) release flux, resulting in impaired contractile activation and force production in skeletal muscle.
Chronic absence of S100A1 results in enhanced L-type Ca2 (show CA2 Antibodies)+ channel activity combined with a blunted sarcoplasmic reticulum Ca2 (show CA2 Antibodies)+ release amplification.
The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21\; however, this gene is located at 21q22.3. This protein may function in Neurite extension, proliferation of melanoma cells, stimulation of Ca2+ fluxes, inhibition of PKC-mediated phosphorylation, astrocytosis and axonal proliferation, and inhibition of microtubule assembly. Chromosomal rearrangements and altered expression of this gene have been implicated in several neurological, neoplastic, and other types of diseases, including Alzheimer's disease, Down's syndrome, epilepsy, amyotrophic lateral sclerosis, melanoma, and type I diabetes.
S100 calcium binding protein A1
, S100 calcium binding protein A1-like
, Protein S100-A1
, S-100 protein alpha chain
, S-100 protein subunit alpha
, S100 alpha
, S100 calcium-binding protein A1
, S100 protein, alpha polypeptide
, protein S100-A1
, protein S100-A13
, S-100 calcium-binding protein, beta chain
, S-100 protein subunit beta
, S100 calcium-binding protein, beta (neural)
, protein S100-B